Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Inventory Average (2021 - 2025)

Kiniksa Pharmaceuticals International (KNSA) has disclosed Inventory Average for 5 consecutive years, with $48.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory Average rose 74.93% year-over-year to $48.1 million, compared with a TTM value of $48.1 million through Dec 2025, up 74.93%, and an annual FY2025 reading of $40.6 million, up 41.35% over the prior year.
  • Inventory Average was $48.1 million for Q4 2025 at Kiniksa Pharmaceuticals International, up from $44.8 million in the prior quarter.
  • Across five years, Inventory Average topped out at $48.1 million in Q4 2025 and bottomed at $4.3 million in Q2 2021.
  • Average Inventory Average over 5 years is $23.5 million, with a median of $24.2 million recorded in 2025.
  • The sharpest move saw Inventory Average soared 290.26% in 2022, then dropped 17.07% in 2025.
  • Year by year, Inventory Average stood at $4.6 million in 2021, then skyrocketed by 290.26% to $18.1 million in 2022, then soared by 56.56% to $28.4 million in 2023, then fell by 2.93% to $27.5 million in 2024, then surged by 74.93% to $48.1 million in 2025.
  • Business Quant data shows Inventory Average for KNSA at $48.1 million in Q4 2025, $44.8 million in Q3 2025, and $35.1 million in Q2 2025.